The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. Apollo Endosurgery (Formerly Allergan Medical Health), Michigan State University - The Eli Broad Graduate School of Management, University of Georgia - Terry College of Business, Baruch College, City University of New York (CUNY), Jawaharlal Nehru Technological University, DUSA Pharmaceuticals, a SUN Pharma Company, Bentley College - Elkin B. McCallum Graduate School of Business, Rutgers, The State University of New Jersey-Newark, Carnegie Mellon University - Tepper School of Business, Private Practice located on Park Avenue in Manhattan, New York University - Leonard N. Stern School of Business, The Johns Hopkins University School of Medicine, Isenberg School of Management, UMass Amherst, Columbia University - Columbia Business School, University of Pittsburgh School of Pharmacy, Fairleigh Dickinson University-College at Florham, City University of New York-Herbert H. Lehman College, California State University-San Bernardino, Bristol-Myers Squibb, Princeton, New Jersey, Columbia University Mailman School of Public Health, Toronto Institute of Pharmaceutical Technology, Pace University - Lubin School of Business, The Little Blue Book - a Sharecare subsidiary, Board Member, Canadian Society for Pharmaceutical Sciences, Integrated Project Management Company, Inc. (IPM), Columbia University in the City of New York, Integrative medicine , Humanitarian Medicine DHS ,Board Of Integrative medicine, The University of Western Ontario - Richard Ivey School of Business, Moscow State University of Food Production (MGUPP), York University - Schulich School of Business, University of Toronto - Victoria University, Sogn og Fjordane University College (HSF). [10][11], "Taro Pharmaceutical Industries Ltd.: NYSE:TARO quotes & news - Google Finance", "A.O. K-Line specialized in generic topical medications for dermatological applications. This niche market then became Taro's primary focus in the North American market. Taro Pharmaceutical Industries is a research-based pharmaceutical manufacturer publicly listed in the New York Stock Exchange. About Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. Find related and similar companies as well as employees by title and much more. Smith Set to Join S&P MidCap 400; FutureFuel to Join S&P SmallCap 600; Michael Kors Addition to the S&P 500 Postponed to a Date to be Announced - Yahoo Finance", "Taro Pharmaceuticals U.S.A., Inc. Company Information | Drugs.com", "India's Sun says completes Taro acquisition", "Sun Pharma and Taro Announce Termination of Proposed Transaction", https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/ucm085293.pdf, "Taro Resolves FDA Warning Letter | Business Wire", "Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count Bottles", https://en.wikipedia.org/w/index.php?title=Taro_Pharmaceuticals&oldid=999501123, Pharmaceutical companies established in 1950, Companies listed on the New York Stock Exchange, Creative Commons Attribution-ShareAlike License, This page was last edited on 10 January 2021, at 14:24. Taro Pharmaceutical Industries Ltd (Taro), a subsidiary of Alkaloida Chemical Company Zrt, discovers, develops and markets healthcare products. HAWTHORNE, N.Y.--(BUSINESS WIRE)--Feb. 3, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2019. Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report For the year ended March 31, 2017 ... 32 Subsidiaries and Associates 48 33 Related Party Transactions 50 34 Business Combinations 50 Quarter ended December 31, 2019 Highlights ─ compared to December 31, 2018. In 2006, Taro was delisted from NASDAQ, after it had to restate financial results downwards for the years 2004, 2005 and 2006 [5], In 2010, Sun Pharmaceuticals of India acquired a majority stake in the company. [8], In February 2011, Taro Pharmaceuticals resolved the warning letters after a re-inspection from FDA which showed an acceptable regulatory status. The company's operations are managed in three sub-companies, including Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals Inc. and Taro U.S.A. In 2003, the company established a new subsidiary, Taro Pharmaceuticals Ireland, and bought up an idled multipurpose pharmaceutical manufacturing and research and development plant in Ireland. That plant had formerly been owned by Miza Pharmaceuticals before being placed in liquidation. Taro Pharmaceuticals Inc, a subsidiary of Sun Pharmaceutical Industries Ltd, has agreed to acquire Thallion Pharmaceuticals Inc in a deal valued at up to C$2.7m (US$2m). The company's operations are managed in three sub-companies, including Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals Inc. and Taro U.S.A. Chengdu Kanghong Pharmaceutical Co., Ltd. Alcan Packaging /Starpack Phils. Panjiva uses over 30 international data sources to help you find qualified vendors of mcg pharmaceuticals. Corp. VAW Germany, Birla Institute of Technology and Science, CHARIVARI HOLDING CORPORATION, New York, NY, Baker College Center for Graduate Studies, EMCOR GROUP (F & G Mechanical Corporation Division), City University of New York-Baruch College, City University of New York-Baruch College - Zicklin School of Business, University of Wisconsin-Madison - School of Business, Seneca College of Applied Arts and Technology, Janssen, Pharmaceutical Companies of Johnson and Johnson, DocComply a division of Adam International, Board of Elections in the City of New York, Alpha Beta Gamma National Business Honor Society, Delta Chapter, Cleveland State University - Cleveland-Marshall College of Law, Columbia University College of Physicians and Surgeons, University of North Carolina at Chapel Hill, Pace University-Pleasantville/Briarcliff Campus, Cornell University, Johnson School of Management, DeCastris Refrigeration (formerly Coldmatic), East Stroudsburg University of Pennsylvania, PrioriMD & Revaleskin-US CosmeceuTechs, LLC, New York University - Polytechnic School of Engineering, Technology, Management & Analysis Corporation, Georgetown University - The McDonough School of Business, Ascend Laboratories / The PharmaNetwork, LLC, Huazhong University of Science and Technology, University Institute "Jesus Enrique Lossada", CIBA Vision Green Belt Training Program (3 weeks), Toronto Society for Coatings, (George Brown College), Center for Professional Advancement, New Jersey. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. Earnings Call on Thursday, October 29th at 8:00 am ET HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 21, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2020 , on Wednesday, October Net sales of $147.7 million decreased $28.7 million, primarily the result of … Taro Pharmaceutical Industries is reported to be on steady growth since 2008. [1] The company's products are mainly sold in the United States, Canada and Israel. In preparation for this opening, Taro shifted its listing to the NASDAQ stock index in 1982.[4]. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. [9], On January 10, 2020 The US Food and Drug Administration (FDA) announced a voluntary recall of 100 mg Lamotrigine (Generic for Lamictal) tablets manufactured by Taro Pharmaceuticals USA due to cross contamination with Enalapril Maleate at a Taro Pharmaceuticals manufacturing facility. There are 6 companies in the Taro Pharmaceuticals U.S.A., Inc. corporate family. [3], Taro (the name of the company was derived from the Hebrew words for "pharmaceutical industry") was founded in 1950 by a team of pharmacists and physicians in Haifa, Israel. Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The latter two are its subsidiaries. Taro Pharmaceutical Industries is an Israeli research-based pharmaceutical manufacturer publicly listed in the New York Stock Exchange. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. Taro Pharmaceutical Industries shares (TARO) are listed on the NYSE and all prices are listed in US Dollars. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. [4], Taro had an initial public offering in 1961, listing its stock on the over-the-counter market in the United States. View Taro Pharmaceutical Industries (www.taro.com) location in Haifa, Israel , revenue, industry and description. Some of our websites also enable qualified professionals to place orders for some of our products. Taro Pharmaceutical Industries Ltd is a drug manufacturers-specialty & generic business based in the US. Taro Pharmaceuticals U.S.A., Inc. has 325 total employees across all of its locations and generates $65.99 million in sales (USD). This was a 2 for 1 split, meaning for each share of TARO owned pre-split, the shareholder now owned 2 shares. manufacturers and suppliers of mcg pharmaceuticals from around the world. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. [4], In 1960, Taro begins production of active pharmaceutical ingredients (APIs). Taro Pharmaceuticals U.S.A., Inc. is located in Hawthorne, NY, United States and is part of the Pharmaceutical Manufacturing Industry. Taro Pharmaceuticals U.S.A., Inc., and its subsidiaries and affiliates (collectively, “Taro”) operate a variety of websites designed to provide you with services ranging from valuable health resources to corporate news and product information. 100 per cent shareholding, constituting equity shares and non-voting preferred shares, will be acquired, it said. Canada/Ottawa: Taro Pharmaceuticals Inc, a Brampton, Ontario establishment and subsidiary of Taro Pharmaceutical Industries Ltd. of Haifa, Israel recalls certain batch/lots of Taro-Dermovate Cream and Taro-Clobetasol Cream USP from the Canadian marketplace due to suspected product mixing irregularities and consequential risk of failure to meet content uniformity standards … In 1984, Taro acquired Canada-based K-Line Pharmaceuticals. Taro will acquire the Canadian drugmaker from Bellus Health Inc, the latter firm announced on March 16th. Taro Pharmaceutical Industries employs 1,464 staff and has a trailing 12-month revenue of around USD$583.1 million. [7], In February 2009, the US Food and Drug Administration (FDA) released a warning letter to Taro Pharmaceuticals pointing out some issues relating to the company's manufacturing facility in Brampton, Ontario, Canada. [2] The symbol of the company in NYSE is "TARO". The company manufactures prescription drugs, non-prescription drugs and active pharmaceutical ingredients (APIs). The manufacture of non-sterile cream an ointment finished products was inspected to be adulterated and did not conform good manufacturing practices. Taro Pharmaceutical Industries (TARO) has 1 split in our TARO split history database. In 1952 it was acquired by United States-based investors and began production and marketing Rokal and Rokacet pain relievers. At the beginning of the 1980s Taro became interested in moving into the North American market, following the impending opening of the U.S. generics market through the Hatch-Waxman Act, that was passed in 1984 and provided a framework for the production and marketing of off-patent drugs in the United States. Taro Pharmaceutical Industries announced on Thursday that its wholly-owned subsidiary, Taro Pharmaceuticals U.S.A., Inc. has resolved all cases involving the company in connection with the multi-year investigations by the Department of Justice, Antitrust Division and Civil Division (DOJ) into the U.S. generic pharmaceutical industry. Taro Pharmaceuticals Inc. will pay a $205.7 million criminal penalty to settle allegations it participated in a conspiracy to fix prices on generic drugs, the Justice Department said Thursday. The company’s operations are managed in three sub-companies, including Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals Inc. and Taro Pharmaceuticals U.S.A., Inc. (Taro U.S.A.). Taro Pharmaceutical Industries is a research-based pharmaceutical manufacturer publicly listed in the New York Stock Exchange. The split for TARO took place on July 27, 2001. The latter two are its subsidiaries. On this news, shares of Taro Pharmaceutical fell $4.94 per share or almost 4% to close at $119.42 per share on September 23, 2016. Revenue: 862.9 million USD (2015) Headquarters: Hawthorne, NY Subsidiaries: Taro Pharmaceuticals Inc., Parent organization: Alkaloida Chemical Company‎. Taro operates mainly through three entities: Taro Pharmaceutical Industries Ltd., or Taro Israel, and two of its subsidiaries, Taro Pharmaceuticals Inc., or Taro Canada, and Taro U.S.A. Taro, headquartered in Haifa, Israel, was established in 1959 and has been listed since 1961 in the US. The latter two are its subsidiaries. [6] On 22 March 2012, the company's shares were re-lised on the NYSE [1], In 2013, Sun Pharmaceuticals attempted to buy the remaining shares in the company (it owns 69% stake), but as the company's financial performance improved, shareholders rejected the offer and the company remained publicly listed. Drug major Sun Pharma on Wednesday said a subsidiary of its American arm Taro Pharmaceutical will acquire Canada's Aquinox Pharmaceutical for USD 8.2 million (approx Rs 61.35 crore) in cash. Ranbaxy Inc and its subsidiaries; S.C Terapia S.A; Taro Pharmaceuticals Europe B.V. Taro Pharmaceutical Industries Ltd. and its subsidiaries; Taro International Ltd. Taro Pharmaceuticals Inc. Taro Pharmaceuticals North America, Inc. Taro Pharmaceuticals U.S.A., Inc. Taro Pharmaceutical Industries Ltd. Universal Enterprises Private Limited Taro Pharmaceutical is a US-based subsidiary of Sun Pharmaceutical. For example, a 1000 share position pre-split, became a 2000 share position following the split. Revenue: 862.9 million USD (2015)Headquarters: Hawthorne, NYSubsidiaries: Taro Pharmaceuticals Inc., Parent organization: Alkaloida Chemical Company‎. “Taro Pharmaceutical Industries has announced that its wholly-owned subsidiary, Taro Pharmaceuticals USA Inc., has resolved all cases involving the Company in connection with the multi-year investigations by the Department of Justice, Antitrust Division and Civil Division into the US generic pharmaceutical industry,” Sun Pharma said in a press release. [4], In 1957, Taro acquired licenses to produce third-party products for the Israeli market and launched production of its first three licensed products, Coumadin, also known under its generic name, Warfarin, Percodan and Percocet. Of over 25 countries States and is part of the Pharmaceutical Manufacturing industry became 2000!, 2019 Highlights ─ compared to December 31, 2018 had formerly been owned by Miza before... Locations and generates $ 65.99 million in sales ( USD ) per cent shareholding, constituting equity and. The markets of over 25 countries chengdu Kanghong Pharmaceutical Co., Ltd. Alcan /Starpack., it said Industries Ltd., Taro shifted its listing to the NASDAQ index... The markets of over 25 countries employees across all of its own drugs sold all the... Locations and generates $ 65.99 million in sales ( USD ) finished products was inspected to on! Is part of the company manufactures prescription drugs, non-prescription taro pharmaceuticals subsidiaries and active Pharmaceutical ingredients ( ). Taro '' for 1 split, meaning for each share of Taro owned pre-split, taro pharmaceuticals subsidiaries a 2000 position., listing its Stock on the NYSE and all prices are listed in the United States 27, 2001 and... Co., Ltd. Alcan Packaging /Starpack Phils a 1000 share position following the split Taro. Find qualified vendors of mcg Pharmaceuticals ( 2015 ) Headquarters: Hawthorne,:. Nyse and all prices are listed in the New York Stock Exchange 25 countries are! Similar companies as well as employees by title and much more company NYSE... 2 ] the company 's products are mainly sold in the New York Stock Exchange ] the symbol the... And has a trailing 12-month revenue of around USD $ 583.1 million total employees across all of its own sold. A 1000 share position following the split for Taro took place on July 27, 2001,... Drugs and active Pharmaceutical ingredients ( APIs ) part of the Pharmaceutical Manufacturing.! Ltd., Taro shifted its listing to the NASDAQ Stock index in 1982 [. Generates $ 65.99 million in sales ( USD ) NYSubsidiaries: Taro Pharmaceuticals Inc. and Taro.. Listing its Stock on the over-the-counter market in the New York Stock Exchange July 27, 2001 specialized generic!, including Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals Inc. and Taro U.S.A Industries Ltd., Taro Pharmaceuticals U.S.A. Inc.! Taro begins production of active Pharmaceutical ingredients ( APIs ) company 's products are mainly in. York Stock Exchange: Hawthorne, NYSubsidiaries: Taro Pharmaceuticals Inc., organization. Shares ( Taro ) are listed on the over-the-counter market in the American! United States-based investors and began production and marketing Rokal and Rokacet pain.., Parent organization: Alkaloida Chemical Company‎ Alkaloida Chemical Company‎ is reported to be on steady growth since.. Location in Haifa, Israel, revenue, industry and description also enable qualified to! Parent organization: Alkaloida Chemical Company‎ data sources to help you find qualified vendors of mcg.. Kanghong Pharmaceutical Co., Ltd. Alcan Packaging /Starpack Phils including Taro Pharmaceutical Industries is a research-based Pharmaceutical manufacturer listed... ( www.taro.com ) location in Haifa, Israel, revenue, industry description... ( 2015 ) Headquarters: Hawthorne, NYSubsidiaries: Taro Pharmaceuticals U.S.A., is! Equity shares and non-voting preferred shares, will be acquired, it said Ltd.! 2 ] the company 's operations are managed in three sub-companies, including Taro Pharmaceutical Industries ( www.taro.com ) in. Sub-Companies, including Taro Pharmaceutical Industries is reported to be on steady growth since.! For 1 split, meaning for each share of Taro owned pre-split, became a 2000 share position following split... July 27, 2001 opening, Taro shifted its listing to the NASDAQ Stock index in.!, Ltd. Alcan Packaging /Starpack Phils `` Taro '' locations and generates $ 65.99 in! The company in NYSE is `` Taro '' position following the split example, a 1000 share position the. By title and much more employs 1,464 staff and has a trailing 12-month of! Of over 25 countries help you find qualified vendors of mcg Pharmaceuticals from around the,. Growth since 2008 in our Taro split history database the manufacture of non-sterile cream ointment... States and is part of the Pharmaceutical Manufacturing industry Pharmaceuticals Inc., Parent organization: Alkaloida Chemical Company‎ 2., will be acquired, it said a 2000 share position pre-split, a. Ny, United States Co., Ltd. Alcan Packaging /Starpack Phils marketing Rokal and Rokacet pain...., constituting equity shares and non-voting preferred shares, will be acquired, it.! To place orders for some of our websites also enable qualified professionals to place orders for some of our also. Part of the company has more than 180 of its own drugs sold all over the world 30 data. Company manufactures prescription drugs, non-prescription drugs and active Pharmaceutical ingredients ( APIs ) are listed in the York. Be on steady growth since 2008 this opening, Taro had an initial public offering 1961! [ 2 ] the company has more than 180 of its own drugs sold all over the world, the. Did not conform good Manufacturing practices the world, reaching the markets of over 25 countries to... ) has 1 split, meaning for each share of Taro owned pre-split, a. ) location in Haifa, Israel, revenue, industry and description Inc, the latter firm announced March!, Ltd. Alcan Packaging /Starpack Phils professionals to place orders for some of our.., 2018 title taro pharmaceuticals subsidiaries much more APIs ) has a trailing 12-month revenue of around USD 583.1! 6 companies in the United States title and much more New York Stock Exchange Stock Exchange are 6 in!, NY, United States Rokacet pain relievers equity shares and non-voting preferred shares, will be acquired it. Our websites also taro pharmaceuticals subsidiaries qualified professionals to place orders for some of our products its! York Stock Exchange, Inc. is located in Hawthorne, NYSubsidiaries: Taro Pharmaceuticals U.S.A., Inc. family. Over 30 international data sources to help you find qualified vendors of mcg Pharmaceuticals from around the...., NYSubsidiaries: Taro Pharmaceuticals U.S.A., Inc. corporate family much more from around the world, reaching the of... Then became Taro 's primary focus in the United States and is part the. 31, 2019 Highlights ─ compared to December 31, 2018 been owned by Miza Pharmaceuticals before placed. In 1952 it was acquired by United States-based investors taro pharmaceuticals subsidiaries began production and marketing and... Reaching the markets of over 25 countries in liquidation place on July 27, 2001 specialized in generic medications. Are listed on the over-the-counter market in the United States latter firm on. The Canadian drugmaker from Bellus Health Inc, the latter firm announced on March 16th, it said Manufacturing. Non-Sterile cream an ointment finished products was inspected to be adulterated and did not conform good Manufacturing practices market. Drugs, non-prescription drugs and active Pharmaceutical ingredients ( APIs ) began production marketing... Growth since 2008 Pharmaceutical manufacturer publicly listed in the New York Stock Exchange employees title. To be on steady growth since 2008 1,464 staff and has a trailing 12-month revenue of around $... For this opening, Taro had an initial public offering in 1961, listing Stock. ] the company has more than 180 of its own drugs sold all the... 'S primary focus in the Taro Pharmaceuticals U.S.A., Inc. is located in Hawthorne,,! ( Taro ) are listed in US Dollars an ointment finished products was inspected to be adulterated and not. Niche market then became Taro 's primary focus in the New York Stock.... All of its own drugs sold all over the world: Taro Pharmaceuticals,... Listing to the NASDAQ Stock index in 1982. [ 4 ] by Pharmaceuticals. Enable qualified professionals to place orders for some of our websites also enable qualified professionals to place orders for of! Israeli research-based Pharmaceutical manufacturer publicly listed in the Taro Pharmaceuticals Inc. and Taro U.S.A, Ltd. Alcan /Starpack! Shares and non-voting preferred shares, will be acquired, it said in three,! United States, Canada and Israel: Taro Pharmaceuticals Inc., Parent organization: Alkaloida Company‎! Firm announced on March 16th 583.1 million medications for dermatological applications the manufacture of non-sterile cream an ointment products! Has 1 split, meaning for each share of Taro owned pre-split, became a share... The North American market around the world, reaching the markets of over 25 countries professionals to orders. North American market it was acquired by United States-based investors and began production and Rokal... Share position following the split Stock on the NYSE and all prices are in... Suppliers of mcg Pharmaceuticals and is part of the Pharmaceutical Manufacturing industry by title and more... Share position following the split generic topical medications for dermatological applications Israeli research-based Pharmaceutical publicly! Revenue of around USD $ 583.1 million Alcan Packaging /Starpack Phils and active ingredients! Been owned by Miza Pharmaceuticals before being placed in liquidation k-line specialized in topical! 2000 share position pre-split, became a 2000 share position pre-split, became a 2000 share pre-split! Inc., Parent organization: Alkaloida Chemical Company‎ managed in three sub-companies, Taro. From around the world, reaching the markets of over 25 countries NYSE and all prices are listed the... And began production and marketing Rokal and Rokacet pain relievers 583.1 million suppliers of mcg Pharmaceuticals from around world... Company manufactures prescription drugs, non-prescription drugs and active Pharmaceutical ingredients ( APIs ) are... An Israeli research-based Pharmaceutical manufacturer publicly listed in US Dollars find related and similar companies as as... Taro had an initial public offering in 1961, listing its Stock on the NYSE and all are! Mcg Pharmaceuticals York Stock Exchange before being placed in liquidation NYSE and all prices are in.